Development of a Synthetic Platform for Ent ‐Pimaranes Reveals their Potential as Novel Non‐Redox Active Ferroptosis Inhibitors
Chemistry – A European Journal · 2025
DOI: 10.1002/chem.202403811 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Immanuel Plangger und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry and Center for Molecular Biosciences, University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria. Hauptthemen laut MEDLINE: Ferroptosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, Austrian Science Fund FWF, European Research Council.
Abstract (Originalsprache)
We present a comprehensive account on the evolution of a synthetic platform for a subfamily of ent ‐pimaranes. For the most complex member, norflickinflimiod C, five distinct strategies relying on either cationic or radical polyene cyclizations to construct the requisite tricyclic carbon scaffold were explored. Insights from early and late stage oxidative and reductive dearomatization studies ultimately led to a mild, rhodium‐catalyzed arene hydrogenation for the final synthetic route. A Sharpless asymmetric dihydroxylation was found to be suitable to render the platform enantioselective and diversification of a late‐stage key intermediate culminated in the total synthesis of eight ent ‐pimaranes in 11–16 steps. These compounds were found to inhibit the formation of pro‐inflammatory leukotrienes and other 5‐lipoxygenase products. Notably, three ent ‐pimaranes exhibited low micromolar, non‐redox active ferroptosis inhibition with remarkable structural specificity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Organic Chemistry and Center for Molecular Biosciences, University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria.
- Michael Popp Institute, University of Innsbruck, Mitterweg 24, 6020, Innsbruck, Austria.
- Department of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria.
- Pharmacognosy / Institute of Pharmaceutical Sciences, University of Graz, Beethovenstraße 8, 8010, Graz, Austria.
ORCID-Profile: Immanuel Plangger, Alex Mühlsteiger, Julian Feilner, Klaus Wurst, Andreas Koeberle, Solveigh C Koeberle, Thomas Magauer
Förderung
- Austrian Science Fund
- Austrian Science Fund FWF
- European Research Council
- HORIZON EUROPE European Research Council
- Tiroler Wissenschaftsförderung
Zitieren
APA
Plangger, I., Mühlsteiger, A., Berger, J., Feilner, J., Wurst, K., Koeberle, A., Koeberle, S. C., & Magauer, T. (2025). Development of a Synthetic Platform for Ent ‐Pimaranes Reveals their Potential as Novel Non‐Redox Active Ferroptosis Inhibitors. Chemistry – A European Journal. https://doi.org/10.1002/chem.202403811
Vancouver
Plangger I, Mühlsteiger A, Berger J, Feilner J, Wurst K, Koeberle A, et al. Development of a Synthetic Platform for Ent ‐Pimaranes Reveals their Potential as Novel Non‐Redox Active Ferroptosis Inhibitors. Chemistry – A European Journal. 2025. doi:10.1002/chem.202403811
BibTeX
@article{Plangger2025,
author = {Plangger, Immanuel and Mühlsteiger, Alex and Berger, Julia and Feilner, Julian and Wurst, Klaus and Koeberle, Andreas and Koeberle, Solveigh C and Magauer, Thomas},
title = {Development of a Synthetic Platform for Ent ‐Pimaranes Reveals their Potential as Novel Non‐Redox Active Ferroptosis Inhibitors},
journal = {Chemistry – A European Journal},
year = {2025},
doi = {10.1002/chem.202403811}
}
EUVIMED